Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

NCT01052402 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

684

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Avian

Interventions

BIOLOGICAL: H5N1 Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated), non-adjuvanted formulation

Sponsor

Alachua Government Services, Inc.